Yu-Ying Chen Selected Research

Yu-Ying Chen Research Topics

Disease

16	Neoplasms (Cancer) 11/2023 - 12/2004
7	Inflammation (Inflammations) 01/2022 - 01/2014
2	Hepatocellular Carcinoma (Hepatoma) 11/2023 - 06/2021
2	Kidney Diseases (Kidney Disease) 08/2021 - 01/2020
2	Mitochondrial Diseases (Mitochondrial Disease) 01/2021 - 07/2014
2	Carcinoma (Carcinomatosis) 09/2009 - 12/2004
1	Hemorrhoids 12/2023
1	Ataxia Telangiectasia (Louis Bar Syndrome) 11/2023
1	Psoriasis (Pustulosis Palmaris et Plantaris) 12/2022
1	Obesity 12/2022
1	Dermatitis 12/2022
1	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2022
1	Endometrial Neoplasms (Endometrial Cancer) 01/2022
1	Retinal Neovascularization 01/2022
1	Pancreatic Neoplasms (Pancreatic Cancer) 11/2021
1	Adenocarcinoma 11/2021
1	Neoplasm Metastasis (Metastasis) 08/2021
1	Liver Neoplasms (Liver Cancer) 06/2021
1	Poisoning 01/2021
1	Fibrosis (Cirrhosis) 01/2020
1	Hyperuricemia 01/2020
1	Cerebral Palsy (Spastic Diplegia) 06/2017
1	Breast Neoplasms (Breast Cancer) 05/2014
1	Skin Manifestations 05/2014
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 10/2013
1	Prostatic Neoplasms (Prostate Cancer) 04/2012
1	Glioma (Gliomas) 06/2011
1	Glioblastoma (Glioblastoma Multiforme) 10/2010
1	Cognitive Dysfunction 06/2010
1	Fistula 12/2009

Drug/Important Bio-Agent (IBA)

4	Biomarkers (Surrogate Marker)IBA 01/2023 - 04/2012
4	andrographolideIBA 07/2014 - 01/2013
3	Proteins (Proteins, Gene)FDA Link 01/2023 - 06/2010
3	CytokinesIBA 01/2023 - 01/2020
3	InflammasomesIBA 01/2022 - 01/2020
3	pterostilbeneIBA 11/2021 - 06/2019
2	AntioxidantsIBA 12/2022 - 01/2022
2	Docetaxel (Taxotere)FDA Link 01/2022 - 05/2014
2	Oxygen (Dioxygen)IBA 11/2021 - 01/2021
2	StilbenesIBA 11/2021 - 06/2019
2	ResveratrolIBA 11/2021 - 06/2019
1	Ointments (Pastes)IBA 12/2023
1	CucurbitacinsIBA 11/2023
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 11/2023
1	Checkpoint Kinase 1IBA 11/2023
1	TabletsIBA 11/2023
1	Histones (Histone)IBA 11/2023
1	Nonprescription Drugs (Patent Medicines)IBA 11/2023
1	cucurbitacin BIBA 11/2023
1	deoxyuridine triphosphateIBA 11/2023
1	DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA 11/2023
1	3-methylquercetinIBA 12/2022
1	Imiquimod (Aldara)FDA LinkGeneric 12/2022
1	Mitomycin (Mitomycin-C)FDA LinkGeneric 01/2022
1	Phosphotransferases (Kinase)IBA 01/2022
1	ginsenoside RdIBA 01/2022
1	palbociclibIBA 01/2022
1	AZD 6244IBA 01/2022
1	Long Noncoding RNAIBA 01/2022
1	olaparibIBA 01/2022
1	Myeloid Differentiation Factor 88IBA 01/2022
1	Heme Oxygenase-1IBA 01/2022
1	Toll-Like Receptor 4IBA 01/2022
1	GinsenosidesIBA 01/2022
1	NF-kappa B (NF-kB)IBA 01/2022
1	Vinblastine (Vinblastine Sulfate)FDA Link 01/2022
1	Retinaldehyde (Retinal)IBA 01/2022
1	Chloroquine (Aralen)FDA LinkGeneric 11/2021
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 11/2021
1	Receptor for Advanced Glycation End ProductsIBA 11/2021
1	Mitogen-Activated Protein KinasesIBA 08/2021
1	cordycepinIBA 08/2021
1	ErbB Receptors (EGF Receptor)IBA 08/2021
1	Glycogen Synthase KinasesIBA 08/2021
1	Adenosine A3 ReceptorIBA 08/2021
1	DAPIIBA 06/2021
1	Matrix Metalloproteinases (MMPs)IBA 06/2021
1	Hemoglobins (Hemoglobin)IBA 01/2021
1	Carbon MonoxideIBA 01/2021
1	Adenine FDA LinkGeneric 01/2020
1	Therapeutic UsesIBA 01/2020
1	CollagenIBA 01/2020
1	potassium oxonateIBA 01/2020
1	Uric Acid (Urate)IBA 01/2020
1	Xanthine OxidaseIBA 01/2020
1	Telomerase (Telomerase Reverse Transcriptase)IBA 06/2019
1	Phospholipases (Phospholipase)IBA 10/2013
1	Nonsense Codon (Nonsense Mutation)IBA 10/2013
1	MicroRNAs (MicroRNA)IBA 04/2012
1	Cyclin D1IBA 06/2011
1	Small Interfering RNA (siRNA)IBA 10/2010
1	SynaptophysinIBA 06/2010
1	Fluorouracil (Carac)FDA LinkGeneric 09/2009
1	Focal Adhesion Protein-Tyrosine KinasesIBA 09/2009

Therapy/Procedure

8	Therapeutics 01/2023 - 06/2007
2	Drug Therapy (Chemotherapy) 01/2023 - 09/2009
1	Radiotherapy 01/2023
1	Immunotherapy 01/2023
1	Prostatectomy (Retropubic Prostatectomy) 04/2012
1	Ligation 12/2009